Anzeige
Mehr »
Login
Sonntag, 19.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
100-Milliarden-Dollar-Marke: Wie die strategische Vision eines Unternehmens historischem Meilenstein passt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DV8N | ISIN: GB00BMXNWH07 | Ticker-Symbol: 85V1
Tradegate
17.01.25
10:41 Uhr
32,303 Euro
-0,333
-1,02 %
Branche
Öl/Gas
Aktienmarkt
Sonstige
1-Jahres-Chart
NOBLE CORPORATION PLC Chart 1 Jahr
5-Tage-Chart
NOBLE CORPORATION PLC 5-Tage-Chart
RealtimeGeldBriefZeit
32,35033,15018.01.
32,44732,84817.01.
PR Newswire
297 Leser
Artikel bewerten:
(1)

Noble Corporation plc: Reporting of transactions made by persons discharging managerial responsibilities

Finanznachrichten News

SUGAR LAND, Texas, Nov. 13, 2024 /PRNewswire/ -- Noble Corporation plc ("Noble") (CSE: NOBLE, NYSE: NE) today announces that the persons listed below (the "PDMRs") have conducted transactions in the A ordinary shares of Noble each with a nominal value of USD 0.00001.

Further details are set out in the notifications below, made in accordance with the requirements of article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (the "Market Abuse Regulation") as amended.

Notification and public disclosure in accordance with the requirements of the Market Abuse Regulation of transactions by persons discharging managerial responsibilities and persons closely associated with them.

Public disclosure of transactions made by Joey Kawaja

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Joey Kawaja

2

Reason for the notification

a)

Position/Status

Senior Vice President Operations

b)

Initial Notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participation, auction platform, auctioneer or auction monitor

a)

Name

Noble Corporation plc

b)

LEI

549300I3HBUNXO0OG954

4

Details of transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)






Description of the financial
instrument, type of instrument

Identification code

Shares

CUSIP-code: G65431127

b)

Nature of the transaction

Sale

c)





Price(s) and volume(s)





Price(s)

Volume(s)

Reference is made to the attached
overview of all trades executed.

Reference is made to the attached

overview of all trades executed.

d)






Aggregated information

- Aggregated volume

- Price

30,000 Shares

USD $35.76

e)

Date of the transaction

2024-11-11

f)

Place of the transaction

New York Stock Exchange (MIC: XNYS)

Individual transaction details: attached

Public disclosure of transactions made by Blake Denton

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Blake Denton

2

Reason for the notification

a)

Position/Status

Senior Vice President Marketing Contracts

b)

Initial Notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participation, auction platform, auctioneer or auction monitor

a)

Name

Noble Corporation plc

b)

LEI

549300I3HBUNXO0OG954

4

Details of transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)






Description of the financial
instrument, type of instrument

Identification code

Shares

CUSIP-code: G65431127

b)

Nature of the transaction

Sale

c)






Price(s) and volume(s)






Price(s)

Volume(s)

Reference is made to the attached

overview of all trades executed.

Reference is made to the attached

overview of all trades executed.

d)






Aggregated information

- Aggregated volume

- Price

30,000 Shares

USD $35.72

e)

Date of the transaction

2024-11-11

f)

Place of the transaction

New York Stock Exchange (MIC: XNYS)

Individual transaction details: attached

About Noble Corporation plc
Noble is a leading offshore drilling contractor for the oil and gas industry. The Company owns and operates one of the most modern, versatile, and technically advanced fleets in the offshore drilling industry. Noble and its predecessors have been engaged in the contract drilling of oil and gas wells since 1921. Noble performs, through its subsidiaries, contract drilling services with a fleet of offshore drilling units focused largely on ultra-deepwater and high specification jackup drilling opportunities in both established and emerging regions worldwide. For further information visit www.noblecorp.com or email investors@noblecorp.com.

IMPORTANT INFORMATION
This announcement is for information purposes only and does not constitute or contain any invitation, solicitation, recommendation, offer or advice to any person to subscribe for or otherwise acquire or dispose of any securities of Noble.

Cision View original content:https://www.prnewswire.co.uk/news-releases/reporting-of-transactions-made-by-persons-discharging-managerial-responsibilities-302304803.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.